Merck Targeting Metabolic Disorders With Advinus Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
Agreement marks Merck’s first research collaboration in India.
You may also be interested in...
Phase II “Baby Boom” A Mixed Blessing
New era calls for sharper scrutiny and creative deals, Windhover panel says.
Phase II “Baby Boom” A Mixed Blessing
New era calls for sharper scrutiny and creative deals, Windhover panel says.
India’s Advinus Signs On With Genzyme In Malaria Research
Development of malaria drugs could qualify Genzyme for a priority review voucher under FDA’s tropical disease incentive.